Solaris Resources Inc. (CVE:SLS – Get Free Report)’s stock price was down 2.7% during mid-day trading on Wednesday . The stock traded as low as C$5.95 and last traded at C$6.15. Approximately 53,313 shares traded hands during mid-day trading, a decline of 60% from the average daily volume of 132,199 shares. The stock had previously closed at C$6.32.
Solaris Resources Trading Down 2.7%
The business has a fifty day moving average price of C$6.15 and a 200 day moving average price of C$6.15.
Solaris Resources Company Profile
SELLAS Life Sciences Group, Inc, a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the treatment of acute myeloid leukemia; and in Phase 1/2 clinical trials for the treatment for ovarian cancer.
Recommended Stories
- Five stocks we like better than Solaris Resources
- What is the Euro STOXX 50 Index?
- Archer’s Recent String of Victories Signals a New Phase of Growth
- Comparing and Trading High PE Ratio Stocks
- 3 Key Stocks Boosting Buybacks Amid Improving Fundamentals
- What is a Death Cross in Stocks?
- The Best AI for Picking Stocks, Ranked by Performance
Receive News & Ratings for Solaris Resources Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Solaris Resources and related companies with MarketBeat.com's FREE daily email newsletter.
